Consensus Claritev Corporation

Stocks

CTEV

US62548M2098

Business Support Services

Real-time Estimate Cboe BZX 12:25:24 15/09/26 am AEST			5-day change	1st Jan Change
37.32 ^USD	+3.72%		-1.21%	-12.85%

10/09	TPG explores $5 billion sale of healthcare software company Lyric, sources say	RE
17/08	Marpai, Inc. Expands Relationship with Claritev Corporation to Help Reduce Healthcare Costs for Employer Clients	CI

Evolution of the Average Target: Claritev Corporation

Evolution of the Target Price: Claritev Corporation

Changes in Analyst Recommendations: Claritev Corporation

7fb6009587100bd3.jyUFnjz11bBKFTS5vwxqtjn8PAdIiqd385_3KZVawRo.931K11SP5vx9enDv3nUY5FzMTDc9zeAfxs6mZ9Fq-C28ZlH2XaSmyBtxZQ~0ccc778d276beb4ab19ff95e8679dc52

Analysts' recommendations: Claritev Corporation

29/05	Canaccord Genuity Initiates Claritev at Buy With $32 Price Target	MT
12/01	Guggenheim Initiates Coverage on Claritev With Buy Rating, $43 Price Target	MT
09/01	Wells Fargo Initiates Claritev Corp at Equalweight With $33 Price Target	MT
22/10/25	Claritev Shares Rise After Upgrade From Citigroup	MT
21/10/25	Citigroup Upgrades Claritev to Buy From Neutral, $55 Price Target	MT
30/05/25	Claritev Shares Rise After Upgrade From Piper Sandler	MT
29/05/25	Piper Sandler Upgrades Claritev to Overweight From Neutral, Adjusts Price Target to $44 From $19	MT
26/06/24	Piper Sandler Initiates MultiPlan at Neutral With $2 Price Target	MT
09/03/23	Citigroup Adjusts Price Target on MultiPlan to $1.25 From $2, Keeps Neutral Rating	MT
19/01/23	Barclays Adjusts Price Target on MultiPlan to $1 From $3, Maintains Equal-Weight Rating	MT
14/12/22	Citigroup Downgrades MultiPlan to Neutral From Buy, Cuts Price Target to $2 From $3	MT
17/11/22	Goldman Sachs Adjusts Price Target on MultiPlan to $2.05 From $5.50, Maintains Neutral Rating	MT
10/11/22	Citigroup Adjusts Price Target on MultiPlan to $3 From $6, Maintains Buy Rating	MT
12/07/22	Goldman Sachs Starts MultiPlan at Neutral With $6.50 Price Target	MT
21/12/21	Citigroup Adjusts MultiPlan's Price Target to $7 from $9, Keeps Buy Rating	MT
11/11/21	Barclays Adjusts MultiPlan's Price Target to $6 From $7, Keeps Equal-Weight Rating	MT
20/08/21	MultiPlan : Tigress Research Initiates Coverage of MultiPlan with Buy Rating, $9 Price Target	MT
07/04/21	MultiPlan : B. Riley Starts MultiPlan at Buy with $10 Price Target; Expects Material Revenue, Earnings Growth Ahead	MT
20/03/21	MultiPlan : Barclays Starts MultiPlan at Equalweight with $7 Price Target	MT
17/11/20	MultiPlan : Citigroup Starts MultiPlan at Buy With $10 Price Target	MT

More recommendations

Data Processing Services

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CLARITEV CORPORATION					+27.39%
	NEBIUS GROUP					+29.46%
	MOBILITY GLOBAL, INC.					+22.02%
	KEHUA DATA CO., LTD.					+41.86%
	SHANGHAI @HUB CO.,LTD.					+23.97%
	JMDC INC.					+25.06%
	Average					+28.29%
	Weighted average by Cap.					+29.09%